Abstract. Starting with the main goals of the Task Force of the European Federation of Psychologists' Associations on Geropsychology, this report presents data from an internet search on European contributions to geropsychology, and from a questionnaire study about research, teaching, and application of geropsychology in Europe with key persons from 30 European countries. Based on these data, conclusions are drawn about future priorities in the field.
In: Alcohol and alcoholism: the international journal of the Medical Council on Alcoholism (MCA) and the journal of the European Society for Biomedical Research on Alcoholism (ESBRA), Band 48, Heft suppl 1, S. i3-i3
<b><i>Background:</i></b> Acamprosate, disulfiram (DIS), naltrexone and nalmefene can be used in treating alcohol use disorders. The drugs are, however, underutilized. <b><i>Methods:</i></b> In this survey of marketing status and perceived efficacy, member societies of the European federation for addiction societies were asked to report on the status of these drugs in their country. Results were obtained from 20 European countries showing that the drugs were registered in most countries. <b><i>Results and Conclusion:</i></b> The drugs were mentioned in guidelines in approximately half and were partially or fully reimbursed in half to two-thirds countries. DIS was perceived as the most efficacious drug. These results are discussed.